See Medpace Holdings's analyst price targets ($600) vs the current share price.
Get informed when a big investor buys or sells
+ Follow$591.29
10 analysts in the last 4 months
High: $692 | Low: $515
No recommendations in the last 4 months.
Medpace Holdings posts a target price of $600. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
A target price of $600 for MEDP means covering analysts, on average, see the stock 1.2% upside of $591.29 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.
Context for MEDP's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Medpace Holdings's other metric pages and overview cover the third.
Judging Medpace Holdings against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $600 here, then scan peer and history charts to see if the gap is persistent.